JP2013523693A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013523693A5 JP2013523693A5 JP2013501851A JP2013501851A JP2013523693A5 JP 2013523693 A5 JP2013523693 A5 JP 2013523693A5 JP 2013501851 A JP2013501851 A JP 2013501851A JP 2013501851 A JP2013501851 A JP 2013501851A JP 2013523693 A5 JP2013523693 A5 JP 2013523693A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- poloxamer
- weight
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims 4
- 229960004194 lidocaine Drugs 0.000 claims 4
- 239000003589 local anesthetic agent Substances 0.000 claims 4
- 229920001983 poloxamer Polymers 0.000 claims 4
- 229960000502 poloxamer Drugs 0.000 claims 4
- -1 polyoxyethylene Polymers 0.000 claims 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
- 229920001400 block copolymer Polymers 0.000 claims 3
- 239000004359 castor oil Substances 0.000 claims 3
- 235000019438 castor oil Nutrition 0.000 claims 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 206010000210 abortion Diseases 0.000 claims 1
- 231100000176 abortion Toxicity 0.000 claims 1
- 235000019445 benzyl alcohol Nutrition 0.000 claims 1
- 230000036760 body temperature Effects 0.000 claims 1
- 210000003679 cervix uteri Anatomy 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000004720 fertilization Effects 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 229940074076 glycerol formal Drugs 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 229960005015 local anesthetics Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229960002409 mepivacaine Drugs 0.000 claims 1
- INWLQCZOYSRPNW-UHFFFAOYSA-N mepivacaine Chemical compound CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C INWLQCZOYSRPNW-UHFFFAOYSA-N 0.000 claims 1
- 125000006353 oxyethylene group Chemical group 0.000 claims 1
- 229920001993 poloxamer 188 Polymers 0.000 claims 1
- 229940044519 poloxamer 188 Drugs 0.000 claims 1
- 229920001992 poloxamer 407 Polymers 0.000 claims 1
- 229940044476 poloxamer 407 Drugs 0.000 claims 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
- 229940068968 polysorbate 80 Drugs 0.000 claims 1
- 229960001807 prilocaine Drugs 0.000 claims 1
- MVFGUOIZUNYYSO-UHFFFAOYSA-N prilocaine Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C MVFGUOIZUNYYSO-UHFFFAOYSA-N 0.000 claims 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 1
- 238000001248 thermal gelation Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1050321 | 2010-04-01 | ||
| SE1050321-7 | 2010-04-01 | ||
| US32541810P | 2010-04-19 | 2010-04-19 | |
| US61/325,418 | 2010-04-19 | ||
| PCT/EP2011/055009 WO2011121074A1 (en) | 2010-04-01 | 2011-03-31 | Thermogelling anaesthetic compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016081084A Division JP2016185950A (ja) | 2010-04-01 | 2016-04-14 | 熱ゲル化麻酔組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013523693A JP2013523693A (ja) | 2013-06-17 |
| JP2013523693A5 true JP2013523693A5 (https=) | 2014-05-22 |
| JP5972862B2 JP5972862B2 (ja) | 2016-08-17 |
Family
ID=44502740
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013501851A Active JP5972862B2 (ja) | 2010-04-01 | 2011-03-31 | 熱ゲル化麻酔組成物 |
| JP2016081084A Pending JP2016185950A (ja) | 2010-04-01 | 2016-04-14 | 熱ゲル化麻酔組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016081084A Pending JP2016185950A (ja) | 2010-04-01 | 2016-04-14 | 熱ゲル化麻酔組成物 |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US8834927B2 (https=) |
| EP (1) | EP2552487B1 (https=) |
| JP (2) | JP5972862B2 (https=) |
| KR (1) | KR101792200B1 (https=) |
| CN (1) | CN102858374B (https=) |
| AU (1) | AU2011234492B2 (https=) |
| BR (1) | BR112012024673B1 (https=) |
| CA (1) | CA2795154C (https=) |
| CL (1) | CL2012002706A1 (https=) |
| CY (1) | CY1118396T1 (https=) |
| DK (1) | DK2552487T3 (https=) |
| EA (1) | EA023396B1 (https=) |
| ES (1) | ES2608850T3 (https=) |
| HR (1) | HRP20161663T1 (https=) |
| HU (1) | HUE031107T2 (https=) |
| IL (1) | IL222224A (https=) |
| LT (1) | LT2552487T (https=) |
| MX (1) | MX2012011262A (https=) |
| MY (1) | MY163215A (https=) |
| NZ (1) | NZ602538A (https=) |
| PH (1) | PH12012501886A1 (https=) |
| PL (1) | PL2552487T3 (https=) |
| PT (1) | PT2552487T (https=) |
| RS (1) | RS55544B1 (https=) |
| SG (1) | SG184071A1 (https=) |
| SI (1) | SI2552487T1 (https=) |
| SM (2) | SMT201700050T1 (https=) |
| WO (1) | WO2011121074A1 (https=) |
| ZA (1) | ZA201206988B (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011121074A1 (en) * | 2010-04-01 | 2011-10-06 | Pharmanest Ab | Thermogelling anaesthetic compositions |
| JP6363115B2 (ja) * | 2013-02-28 | 2018-07-25 | ミラ ファーマ コーポレイション | 注射可能局所麻酔半固体製剤およびその組成物 |
| US10220093B2 (en) | 2013-02-28 | 2019-03-05 | Mira Pharma Corporation | Long-acting semi-solid lipid formulations |
| GB201305622D0 (en) * | 2013-03-27 | 2013-05-15 | Sas Ltd | Composition |
| CA2961660A1 (en) * | 2014-10-01 | 2016-04-07 | Als Mountain Llc | Pharmaceutical composition comprising aspirin, metformin, and serotonin with non-ionic surfactant |
| AU2016237984B2 (en) | 2015-03-25 | 2019-01-31 | Terumo Kabushiki Kaisha | Gel type local anesthetic agent and gel type local anesthetic preparation using same |
| WO2017082121A1 (ja) | 2015-11-12 | 2017-05-18 | テルモ株式会社 | 徐放性局所投与剤 |
| CN105769839B (zh) * | 2016-05-17 | 2019-06-11 | 山西远扬医药科技有限公司 | 一种复方利多卡因药物组合物及其制备方法 |
| CN107149697B (zh) * | 2017-03-24 | 2020-07-31 | 王科 | 一种皮肤表面麻醉敷料、其制备方法及使用方法 |
| US10561606B2 (en) | 2017-12-06 | 2020-02-18 | Mira Pharma Corporation | Injectable long-acting local anesthetic semi-solid gel formulations |
| US11426418B2 (en) | 2017-12-06 | 2022-08-30 | Mira Pharma Corporation | Injectable long-acting semi-solid gel formulations |
| CN108309928A (zh) * | 2018-03-22 | 2018-07-24 | 兆科（广州）眼科药物有限公司 | 一种妇科术后止痛药物组合物及其制备方法 |
| IT201800004036A1 (it) * | 2018-03-28 | 2019-09-28 | Teres Srl | Gel transdermico |
| WO2019217536A1 (en) * | 2018-05-08 | 2019-11-14 | University Of Connecticut | Long-acting local anesthetic formulation |
| CN111840553A (zh) * | 2019-04-15 | 2020-10-30 | 湖州依诺唯新药物制剂有限公司 | 脂性药物制剂及其应用 |
| JP7646175B2 (ja) * | 2019-11-28 | 2025-03-17 | 東洋製薬化成株式会社 | リドカイン含有外用医薬組成物 |
| EP4110293A4 (en) * | 2020-02-25 | 2024-07-10 | The University of North Carolina at Chapel Hill | EUTECTIC-BASED ANESTHESIC COMPOSITIONS AND CORRESPONDING APPLICATIONS |
| US12508221B2 (en) * | 2020-09-11 | 2025-12-30 | PS Therapy Ltd | Topical compositions and methods of use |
| JP2025504173A (ja) * | 2022-02-04 | 2025-02-06 | インタクト セラピューティクス， インコーポレイテッド | メサラミン薬学的製剤およびその使用法 |
| US12514756B1 (en) | 2024-10-08 | 2026-01-06 | Covidien Lp | Dermal patch and systems, kits, and methods associated therewith |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1248014B (it) * | 1991-06-07 | 1995-01-05 | Inverni Della Beffa Spa | Preparazioni oftalmiche a rilascio protratto |
| SE9601421D0 (sv) | 1996-04-12 | 1996-04-12 | Astra Ab | New composition |
| US6217900B1 (en) * | 1997-04-30 | 2001-04-17 | American Home Products Corporation | Vesicular complexes and methods of making and using the same |
| JP3782551B2 (ja) * | 1997-06-24 | 2006-06-07 | 鉄郎 高山 | 鎮痛組成物 |
| US6528086B2 (en) | 1999-09-28 | 2003-03-04 | Zars, Inc. | Methods and apparatus for drug delivery involving phase changing formulations |
| KR100416646B1 (ko) | 2000-08-14 | 2004-02-05 | 구주제약주식회사 | 리도카인을 함유한 조루치료용 마이크로에멀젼 하이드로겔 제형의 약학 조성물 |
| GB0120701D0 (en) | 2001-08-24 | 2001-10-17 | Maelor Pharmaceuticals Ltd | Pharmaceutical formulations |
| GB0120702D0 (en) * | 2001-08-24 | 2001-10-17 | Maelor Pharmaceuticals Ltd | Anaesthetic formulations |
| US20040220283A1 (en) | 2002-07-29 | 2004-11-04 | Transform Pharmaceuticals, Inc. | Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| CN100438861C (zh) * | 2002-07-29 | 2008-12-03 | 变换药品公司 | 含水2,6-二异丙基苯酚药物组合物 |
| AU2003900887A0 (en) * | 2003-02-27 | 2003-03-13 | Novasel Australia Pty Ltd | Poloxamer emulsion preparations |
| ES2237298B1 (es) * | 2003-07-16 | 2006-11-01 | Italfarmaco, S.A. | Formulaciones mucoadhesivas semisolidas. |
| US20050084508A1 (en) | 2003-07-22 | 2005-04-21 | Vancaillie Thierry G. | Topical anesthesia formulation for bodily cavities |
| AU2005294805B2 (en) | 2004-05-28 | 2012-02-16 | Oryxe | A mixture for transdermal delivery of low and high molecular weight compounds |
| US20070190124A1 (en) | 2004-06-07 | 2007-08-16 | Jie Zhang | Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs |
| AU2006201233B2 (en) | 2006-03-24 | 2010-10-07 | Alan Hewitt | Topical anesthesia formulation for bodily cavities |
| US20070298005A1 (en) | 2006-06-22 | 2007-12-27 | Marie-Josee Thibault | Injectable composition for treatment of skin defects or deformations |
| JP5189093B2 (ja) * | 2006-07-31 | 2013-04-24 | ラボラトワール・ベザン・ザンテルナショナル | 過剰瘢痕化の治療および予防 |
| JP5301205B2 (ja) * | 2008-05-28 | 2013-09-25 | 東興薬品工業株式会社 | ゲル軟膏組成物 |
| WO2011121074A1 (en) * | 2010-04-01 | 2011-10-06 | Pharmanest Ab | Thermogelling anaesthetic compositions |
-
2011
- 2011-03-31 WO PCT/EP2011/055009 patent/WO2011121074A1/en not_active Ceased
- 2011-03-31 CA CA2795154A patent/CA2795154C/en active Active
- 2011-03-31 DK DK11714956.7T patent/DK2552487T3/en active
- 2011-03-31 EP EP11714956.7A patent/EP2552487B1/en active Active
- 2011-03-31 NZ NZ602538A patent/NZ602538A/en unknown
- 2011-03-31 ES ES11714956.7T patent/ES2608850T3/es active Active
- 2011-03-31 SG SG2012068243A patent/SG184071A1/en unknown
- 2011-03-31 MY MYPI2012004370A patent/MY163215A/en unknown
- 2011-03-31 PH PH1/2012/501886A patent/PH12012501886A1/en unknown
- 2011-03-31 EA EA201290789A patent/EA023396B1/ru unknown
- 2011-03-31 SI SI201131070A patent/SI2552487T1/sl unknown
- 2011-03-31 HU HUE11714956A patent/HUE031107T2/en unknown
- 2011-03-31 PT PT117149567T patent/PT2552487T/pt unknown
- 2011-03-31 KR KR1020127028635A patent/KR101792200B1/ko active Active
- 2011-03-31 PL PL11714956T patent/PL2552487T3/pl unknown
- 2011-03-31 SM SM20170050T patent/SMT201700050T1/it unknown
- 2011-03-31 BR BR112012024673-9A patent/BR112012024673B1/pt not_active IP Right Cessation
- 2011-03-31 US US13/638,511 patent/US8834927B2/en active Active
- 2011-03-31 JP JP2013501851A patent/JP5972862B2/ja active Active
- 2011-03-31 AU AU2011234492A patent/AU2011234492B2/en active Active
- 2011-03-31 LT LTEP11714956.7T patent/LT2552487T/lt unknown
- 2011-03-31 CN CN201180016573.8A patent/CN102858374B/zh active Active
- 2011-03-31 MX MX2012011262A patent/MX2012011262A/es active IP Right Grant
- 2011-03-31 RS RS20161049A patent/RS55544B1/sr unknown
- 2011-03-31 HR HRP20161663TT patent/HRP20161663T1/hr unknown
-
2012
- 2012-09-18 ZA ZA2012/06988A patent/ZA201206988B/en unknown
- 2012-09-27 IL IL222224A patent/IL222224A/en active IP Right Grant
- 2012-09-27 CL CL2012002706A patent/CL2012002706A1/es unknown
-
2014
- 2014-02-04 US US14/172,794 patent/US8828437B2/en active Active
- 2014-07-18 US US14/335,563 patent/US9254263B2/en active Active
-
2016
- 2016-04-14 JP JP2016081084A patent/JP2016185950A/ja active Pending
- 2016-12-30 CY CY20161101360T patent/CY1118396T1/el unknown
-
2017
- 2017-01-23 SM SM201700050T patent/SMT201700050B/it unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013523693A5 (https=) | ||
| NZ602538A (en) | Thermogelling anaesthetic compositions | |
| JP2013523694A5 (https=) | ||
| HRP20140716T1 (hr) | Analozi oksitocina | |
| ES3023559T3 (en) | Pharmaceutical composition comprising cannabidiol and hyaluronic acid | |
| Syed et al. | Human leukocyte derived interferon-alpha in a hydrophilic gel for the treatment of intravaginal warts in women: a placebo-controlled, double-blind study | |
| WO2014119836A1 (en) | Pharmaceutical composition for protecting wounds, providing hemostasis, or preventing adhesion in the gastrointestinal tract | |
| JP2023503373A (ja) | 新規多機能オリゴペプチド | |
| WO2018049326A1 (en) | Combination gel for sexually transmitted infections | |
| CA2445506C (en) | Use of sucralfate for the treatment of cervical erosion | |
| JP2018109034A (ja) | 避妊殺菌剤の効果を増強するための組成物および方法 | |
| CN114452298A (zh) | 使用基于藻酸的抗微生物化合物抑制炎症和疾病的组合物和方法 | |
| JP2007533604A (ja) | ヒドロキシエチルセルロースに基づく生体接着性ゲル | |
| KR102089117B1 (ko) | 올리고머 락트산을 포함하는 약제학적 조성물 | |
| CN103340822B (zh) | 益康唑或其盐阴道膨胀栓及其制备方法和检测方法 | |
| CN103751098B (zh) | 重组人干扰素α2а阴道膨胀栓及其制备方法和检测方法 | |
| CN104138350A (zh) | 一种黄芩素温敏凝胶及其制备方法和应用 | |
| CN103379899A (zh) | 用于治疗子宫颈非典型性增生或子宫颈癌的包含亚硒酸盐或含亚硒酸盐化合物的药物制剂 | |
| CN103251550A (zh) | 含有秋水仙碱的透皮给药膏剂及其制备方法 | |
| CN105012938A (zh) | 重组人干扰素α2b阴道膨胀栓及其制备方法和检测方法 | |
| CN104434885A (zh) | 一种快速释放药物的水溶性高分子膜及制备方法 | |
| CN115025209B (zh) | 一种含溶菌酶的私护凝胶 | |
| CN101647954B (zh) | 一种用于治疗宫颈炎的中药膜剂及其制备方法和应用 | |
| CN111870644A (zh) | 一种治疗妇科疾病的配方及制备方法 | |
| RU2747987C1 (ru) | Композиция для лечения латентной и субклинической папилломавирусной инфекции шейки матки и способ ее применения |